US 12202886
Neutralizing antibodies to GP120 and their use
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 12202886 (Neutralizing antibodies to GP120 and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jan 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61P, A61P31/18